advertisement
9.2.1 Ocular hypertension (39)
Showing records 1 to 25
Display all abstracts in classification 9.2.1 Ocular hypertension
Search within classification 9.2.1 Ocular hypertension69320 Technology and the Glaucoma Suspect
Blumberg DM
Investigative Ophthalmology and Visual Science 2016; 57: OCT80-5
69077 Retinal vessel diameter in bilateral glaucoma suspects: comparison between the eye converted to glaucoma and the contralateral non-converted eye
Yoo E
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1599-1608
69172 Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
Aptel F
Current Medical Research and Opinion 2016; 32: 1457-1463
69023 Tafluprost Ophthalmic Solution 0.0015Â %: A Review in Glaucoma and Ocular Hypertension
Keating GM
Clinical Drug Investigation 2016; 36: 499-508
69465 Diagnosis and treatment of ocular hypertension
Sun YY
Chinese Journal of Ophthalmology 2016; 52: 542-546
69333 Structure-Function Relationship between Flicker-Defined form Perimetry and Spectral-Domain Optical Coherence Tomography in Glaucoma Suspects
Reznicek L
Current Eye Research 2016; 0: 1-6
69143 Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Chabi A
International Journal of Clinical Pract 2016; 70: 577-586
69318 Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes
Yarmohammadi A
Investigative Ophthalmology and Visual Science 2016; 57: OCT451-9
68950 Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up
Salvetat ML
Eye 2016; 30: 784-795
69305 Differentiation of ocular hypertension
Hoffmann EM
Ophthalmologe 2016; 113: 715-728
69002 Assessing Precision of Hodapp-Parrish-Anderson Criteria for Staging Early Glaucomatous Damage in an Ocular Hypertension Cohort: A Retrospective Study
Chakravarti T
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2016; 0:
69077 Retinal vessel diameter in bilateral glaucoma suspects: comparison between the eye converted to glaucoma and the contralateral non-converted eye
Yoo C
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1599-1608
69465 Diagnosis and treatment of ocular hypertension
Chen WW
Chinese Journal of Ophthalmology 2016; 52: 542-546
69333 Structure-Function Relationship between Flicker-Defined form Perimetry and Spectral-Domain Optical Coherence Tomography in Glaucoma Suspects
Muth D
Current Eye Research 2016; 0: 1-6
69143 Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Baranak C
International Journal of Clinical Pract 2016; 70: 577-586
68950 Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up
Zeppieri M
Eye 2016; 30: 784-795
69172 Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
Choudhry R
Current Medical Research and Opinion 2016; 32: 1457-1463
69305 Differentiation of ocular hypertension
Lamparter J
Ophthalmologe 2016; 113: 715-728
69318 Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes
Zangwill LM
Investigative Ophthalmology and Visual Science 2016; 57: OCT451-9
69320 Technology and the Glaucoma Suspect
De Moraes CG; Liebmann JM
Investigative Ophthalmology and Visual Science 2016; 57: OCT80-5
69465 Diagnosis and treatment of ocular hypertension
Wang NL
Chinese Journal of Ophthalmology 2016; 52: 542-546
69333 Structure-Function Relationship between Flicker-Defined form Perimetry and Spectral-Domain Optical Coherence Tomography in Glaucoma Suspects
Vogel M
Current Eye Research 2016; 0: 1-6
69318 Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes
Diniz-Filho A
Investigative Ophthalmology and Visual Science 2016; 57: OCT451-9
69143 Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Lupinacci R
International Journal of Clinical Pract 2016; 70: 577-586
68950 Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up
Tosoni C
Eye 2016; 30: 784-795
